| 1973 |
Reflecting on our history, since our founding in 1973, we have expanded our business through the import and sale of fracture treatment materials. |
| 1973 |
Since its founding in 1973, the company has expanded its business through the import and sale of fracture treatment materials. |
| 1973-05 |
Established Hospital Services Co., Ltd. (capital 2.5 million yen) for the purpose of selling medical-related products |
| 1981-01 |
Renamed to Japan M.D.M Co., Ltd. |
| 1981-07 |
Commenced sales of bone bonding materials as the sole distributor of Ace Medical Company (USA) in Japan |
| 1994 |
Entered the U.S. market in 1994. |
| 1994-09 |
Acquired Ortho Development Corporation (USA) (hereafter ODEV) |
| 1996-01 |
Commenced sales of the ODC bipolar system artificial joint manufactured by ODEV |
| 1998-12 |
Registered shares as listed securities with the Japan Securities Dealers Association and went public |
| 2000-02 |
Commenced sales of spinal fixation devices manufactured by ODEV |
| 2000-03 |
Listed shares on the Second Section of the Tokyo Stock Exchange |
| 2001-05 |
Listed shares on the First Section of the Tokyo Stock Exchange |
| 2004-07 |
Obtained ISO 13485 certification for medical device quality management system |
| 2007-06 |
Signed an exclusive sales agreement for bone bonding materials in the Japanese market with Johnson & Johnson Medical Company |
| 2007-06 |
Signed an exclusive sales agreement for bone joint materials in the Japanese market with Johnson & Johnson Medical Company. |
| 2008-07 |
Signed a capital and business alliance agreement with Itochu Corporation |
| 2009-08 |
Signed a new sales partnership agreement for bone bonding materials and related products in the Japanese market with Johnson & Johnson Medical Company from January 2010 onward |
| 2009-08 |
Signed a sales partnership agreement with Omic Co., Ltd. |
| 2010-12 |
ODEV carried out a shareholder allocation capital increase. |
| 2012 |
In 2012, we strengthened our manufacturing capabilities and transitioned from a trading company to a manufacturer to provide treatment materials suitable for the Japanese skeleton. |
| 2012-03 |
Started selling its own developed bone joint material product in Japan. |
| 2012-06 |
Ended the sales agreement for bone joint materials in the Japanese market with Johnson & Johnson Medical Company. |
| 2016-05 |
Ended the capital and business partnership agreement with Itochu Corporation. |
| 2016-05 |
Signed a capital and business partnership agreement with Nihon Special Ceramics Co., Ltd. |
| 2018-06 |
ODEV carried out a shareholder allocation capital increase. |
| 2018-10 |
Signed a sales partnership agreement with Nakashima Medical Co., Ltd. (now Teijin Nakashima Medical Co., Ltd.). |
| 2018-10 |
Signed a sales partnership agreement with Teijin Nakashima Medical Co., Ltd. (now Nakashima Health Force Co., Ltd.). |
| 2018-10 |
ODEV Corporation has signed a sales partnership agreement for "KASM" with DePuy Synthes Sales, Inc. |
| 2020-06 |
ODEV signed an exclusive sales partnership agreement with Changzhou Waston Medical Appliance Co., Ltd. (Changzhou Waston Medical Appliance Co., Ltd.) (hereinafter referred to as WASTON). |
| 2021 |
In 2021, we expanded into the Chinese market and are promoting initiatives to realize our philosophy of contributing to healthcare. |
| 2021 |
In 2021, the company also entered the Chinese market and is promoting initiatives to realize its philosophy of "contributing to healthcare." |
| 2021-02 |
ODEV entered into an agreement to establish a joint venture, Changzhou Waston Ortho Medical Appliance Co., Limited (Changzhou Waston Ortho Medical Appliance Co., Ltd.) in China, with WASTON. |
| 2022-01 |
Ended the capital and business partnership agreement with Nihon Special Ceramics Co., Ltd. |
| 2022-01 |
Signed a capital and business partnership agreement with Mitsui Chemicals Inc. |
| 2022-04 |
Moved from the First Section of the Tokyo Stock Exchange to the Prime Market due to a review of market classifications. |
| 2025-03 |
Launched sales of the 'JMDM BIOCERAM AZUL Ceramic Head' developed under a development outsourcing agreement with Kyocera Corporation. |
